TGA Approval

ERBITUX cetuximab (rmc) 500mg/100mL solution for intravenous infusion (132396)

ARTG ID

132396

ARTG Name

ERBITUX cetuximab (rmc) 500mg/100mL solution for intravenous infusion

Sponsor

Merck Healthcare Pty Ltd

ARTG Date

September 25, 2007

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Merck Healthcare Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-01424-3

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-01421-3

Ingredient Name

Cetuximab

Empowering clinical research with data-driven insights and AI-powered tools.

ERBITUX cetuximab (rmc) 500mg/100mL solution for intravenous infusion (132396) - TGA 批准文号 | MedPath